Publications

TitlePersistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
AuthorsChristopher J Gill, Roger Baxter, Alessandra Anemona, Giuseppe L Ciavarro, and Peter M Dull
PublicationHuman Vaccine. 2010 Nov; 6(11):881–887.
AbstractThe persistence of human bactericidal activity (hSBA) responses in adolescents was assessed 22 months after vaccination with one dose of Menveo® (MenACWY-CRM; Novartis) or Menactra® (MCV4) (sanofi pasteur). The proportion of subjects with hSBA titers ≥8 was significantly higher among recipients of MenACWY-CRM than MCV4 for serogroups A, W-135 and Y.
URLhttp://www.landesbioscience.com/